兽药展览会观察|“减抗”背后,兽药产业正在发生什么?
calendar_today2026年6月20日

兽药展览会观察|“减抗”背后,兽药产业正在发生什么?

2026年6月,第十二届兽药展览会在合肥滨湖国际会展中心举办。本届展会以“激活创新动能,重塑行业价值”为主题,集中展示了兽药产业链的最新成果与技术趋势。在“减抗”政策持续推进、合规要求不断提升的背景下,这场展会折射出的不是单一产品的更新,而是整个兽药产业增长逻辑的深层变化。

过去,行业关注的是“用什么药、卖多少药、铺多少渠道”。今天,行业必须回答更根本的问题:如何减少不必要的用药?如何让用药更有依据?如何将疾病管理前移至预防、检测与长期健康管理?

“减抗”不是兽药产业的刹车,而是一次换挡。

一、从“治病”到“防病”:价值链正在向前移动

很长一段时间里,兽药的价值更多体现在疾病发生之后。“减抗”真正推动的,是行业从“事后治疗”转向“事前预防”。在宠物医疗端,预防意味着更早识别健康异常,将一次突发就诊转化为长期健康管理。

兽药产业的价值不再只集中于药品本身,而是扩展到检测、诊断、免疫、营养、护理、数据记录等更长的链条之中。

二、从“经验用药”到“精准用药”:回归证据本身

减抗并不是不用药,而是反对盲目用药、重复用药和缺乏依据的用药。精准用药的前提是精准识别,精准识别的基础是检测与数据。

三、跨界融合加速:兽药产业边界正在被重新打开

未来的行业竞争,不再是单一产品之间的竞争,而是系统能力之间的竞争。谁能把“检测—诊断—用药—护理—复查—归档”串联起来,谁就能在新的产业周期中获得更强话语权。

四、行业趋势:减抗倒逼从“销售导向”走向“健康导向”

药品仍然重要,但不再孤立存在。它必须进入一个更完整的解决方案:前端有筛查,中端有诊断,后端有治疗,之后还有访视和复盘。这将推动企业从“产品供应商”走向“健康方案提供者”。

五、贝芯宠的观察:AI的价值在于辅助判断

作为关注宠物数字健康管理的企业,贝芯宠看到动物健康产业正从经验驱动走向数据驱动和智能辅助驱动。宠医AI诊疗助手的价值,在于辅助医生完成信息整理、病历生成、检查资料分析与诊疗思路提示。

结语:更理性的增长

第十二届兽药展览会呈现的,不只是新品与技术,更是行业未来的主线:从治疗走向预防,从经验走向证据,从单品走向系统,从销售走向健康管理。

贝芯宠将继续关注AI、数据与动物健康管理的融合,为行业提供更专业的宠物医疗AI解决方案。

Veterinary Drug Exhibition Insight: What Is Happening Behind Antibiotic Reduction?
calendar_todayJUN 20, 2026

Veterinary Drug Exhibition Insight: What Is Happening Behind Antibiotic Reduction?

In June 2026, the 12th Veterinary Drug Exhibition was held at Hefei Binhu International Convention and Exhibition Center, showcasing the latest achievements and industry trends across the veterinary pharmaceutical chain. Against the backdrop of advancing antibiotic reduction policies, the exhibition reflected not merely product updates but a fundamental shift in the industry growth logic.

Antibiotic reduction is not a brake on the veterinary pharmaceutical industry - it is a gear shift.

1. From Treatment to Prevention: The Value Chain Is Moving Forward

Antibiotic reduction is driving a shift from reactive treatment to proactive prevention. For pet healthcare, prevention means earlier identification of health abnormalities, transforming urgent visits into ongoing health management.

2. From Empirical to Precision Medication: Back to Evidence

Antibiotic reduction does not mean eliminating medication - it opposes blind, repetitive, and unsubstantiated use. Precision medication requires objective diagnostic results and standardized treatment protocols.

3. Cross-Industry Integration: Reshaping Industry Boundaries

Future competition will be between systemic capabilities, not individual products. Those who can connect detection, diagnosis, medication, care, follow-up, and archiving will gain stronger influence in the new industry cycle.

4. From Sales-Oriented to Health-Oriented

Growth will come from professional health management, precise medication guidance, and trustworthy service systems - driving companies from product suppliers to health solution providers.

5. Begin Petcare: AI Value Is in Assistance, Not Replacement

Begin Petcare sees the animal health industry moving from experience-driven to data-driven and AI-assisted models. The value of AI diagnosis assistance tools lies in helping veterinarians with information organizing, medical record generation, and diagnostic analysis.

Conclusion: Toward Rational Growth

The 12th Veterinary Drug Exhibition revealed a clear trajectory: from treatment to prevention, from experience to evidence, from single products to systems, from sales to health management.

Begin Petcare will continue contributing AI-powered solutions to this transformation.